CME Information
Provider Statement: This continuing education activity is provided by 
Support Statement: This activity is supported by educational grants from Novartis Pharmaceuticals Corporation; Sanofi Genzyme; and Teva Pharmaceuticals.
Education activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants will be advised that accredited status as a provider refers only to its continuing education activities and does not imply American Nurses Credentialing Center’s Commission on Accreditation endorsement of any commercial products.
Target Audience: The intended audience for the activities is neurologists, neurology nurses and other health care professionals involved in the treatment of patients with MS.
Purpose/Learning Objective:
Upon successful completion of this educational activity, participants should be better able to examine the burden of disease and treatment nuances in special populations of patients with MS.
Faculty:
Bruce A. Cohen, MD, FAAN, FANA, FACP
Professor of Neurology
Northwestern University
Feinberg School of Medicine
Director
Northwestern Comprehensive Multiple Sclerosis Program
Chicago, IL
Reviewers:
Brian M. Shepler, PharmD
Barbara A. Niedz, PhD, RN, CPHQ
Amy Perrin Ross, APN, MSN, CNRN, MSCN
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP (Recertification review on 11/14/2018)
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.
Faculty report the following relationship(s) which are accurate at the time of original content release (11/28/2017):
Bruce A. Cohen, MD, FAAN, FANA, FACP
Consulting Fee: Biogen-Idec, EMD-Serono
Reviewers report the following relationship(s):
Brian M. Shepler, PharmD
No relevant financial relationships to disclose.
Barbara A. Niedz, PhD, RN, CPHQ
No relevant financial relationships to disclose.
Amy Perrin Ross, APN, MSN, CNRN, MSCN
Consulting Fee: Acorda, Genentech, Genzyme
Speakers Bureau: Acorda, Biogen, EMD-Serono, Genzyme, Mallinckrodt, Novartis, Teva
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Accreditation:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Vindico Medical Education, LLC, is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Vindico Medical Education will provide 0.25 contact hours for nurses.
This activity was originally approved for 1 year from the date of original release, November 28, 2017 to November 27, 2018. It has since been recertified for an additional year and will now expire on November 14, 2019.
How To Participate in this Activity and Obtain CME/CNE Credit:
To participate in this CME/CNE activity, you must read the objectives, answer the pretest question, read the article, and complete the CME/CNE posttest and the evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering the posttest question correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ or Learner-Paced Contact Hour(s) Certificate.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2017 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME/CNE Questions?
Contact us at cme@vindicoCME.com